CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multip

来源 :第十四届全国肿瘤生物治疗大会 | 被引量 : 0次 | 上传用户:philipsyin
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Adoptive immunotherapy with T cells expressing a tumor-associated chimeric antigen receptor (CAR) provides a promising approach for tumor therapy.We designed a clinical trial for multiple myeloma (MM) treatment with CAR-modified T cells recognizing CD138 (CART-138).
其他文献
会议
Viral entry is initiated by attachment of the virion to functional receptor(s) followed by uncoating to release the viral genome.This process is rather well-cha
会议
会议
Rapid development of nanotechnology has stimulated considerable interest in their applications in life sciences.In particular, several unique features of nanopa
会议
会议
"Life is endless series of Decision, regardless of fruit fly Drosophila or Human beings".We have designed acolor/positiondilemma in the visual flight simulator.
会议
Memories as subjective experiences are encoded in the brain by distributed populations of neurons.In order to study the formation, dynamics and decay of memory
会议
Mechanisms of PPR and macromolecular conformation changes that control the efficiency of energy transduction in photosynthesis are discussed.Special attention i
会议
  Aluminum-containing adjuvants (alum) continue to be the most widely used adjuvants.It is common knowledge that these adjuvants predominantly induce humoral
会议
  Mesenchymal stem cells (MSCs) represent a heterogenous population of adult, fibroblast-like multi-potent cells.MSCs have drawn much attention during the las
会议